TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up

Insider Trading

Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.

All Recent Buys Recent Sells
Reset
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).
Ticker Insider Title Date Transaction Price ($) Shares Value ($) SEC Form 4
SFST Cubbage Leighton M Director 09/02/2026 Verkauf 62.40 400 24,960 Form 4
SFST Cubbage Leighton M Director 09/02/2026 Verkauf 62.50 300 18,750 Form 4
SMID Smith Matthew I Director 09/02/2026 Zuteilung 27.15 2,000 54,300 Form 4
SHEN Schultz Leigh Ann Director 09/02/2026 Zuteilung 12.37 54 668 Form 4
SHEN Rhymes Michael Anthony Director 09/02/2026 Zuteilung 12.37 40 495 Form 4
SHEN Quaglio Kenneth L Director 09/02/2026 Zuteilung 12.37 81 1,002 Form 4
SHEN Koontz Richard L Jr Director 09/02/2026 Zuteilung 12.37 40 495 Form 4
SHEN Beckett Thomas Director 09/02/2026 Zuteilung 12.37 32 396 Form 4
SHEN Barnes Victor Christopher Director 09/02/2026 Zuteilung 12.37 66 816 Form 4
SUJA Paine Schwartz Food Chain Fund V Gp, Ltd. 10% Owner 09/02/2026 Kauf 10.26 175,000 1,795,500 Form 4
SLNH OReilly Mary Jennifer Chief People Officer 09/01/2026 Steuer-Abgabe 1.05 16,189 16,998 Form 4
SLNH Thomas Jessica L. Chief Accounting Officer 09/01/2026 Steuer-Abgabe 1.05 5,343 5,610 Form 4
SYM Kane Charles Director 09/01/2026 Verkauf 39.00 2,000 78,000 Form 4
SYM Kane Charles Director 09/01/2026 J — 2,000 — Form 4
STOK Ticho Barry CHIEF MEDICAL OFFICER 09/01/2026 Verkauf 31.06 1,600 49,691 Form 4
STOK Ticho Barry CHIEF MEDICAL OFFICER 09/01/2026 Verkauf 30.51 3,945 120,370 Form 4
SYRE King-Jones Heidy See Remarks 09/01/2026 Verkauf 89.38 400 35,752 Form 4
SYRE King-Jones Heidy See Remarks 09/01/2026 Verkauf 88.17 6,206 547,183 Form 4
SYRE King-Jones Heidy See Remarks 09/01/2026 Verkauf 87.20 16,548 1,442,986 Form 4
SYRE King-Jones Heidy See Remarks 09/01/2026 Verkauf 86.40 4,845 418,608 Form 4
SYRE King-Jones Heidy See Remarks 09/01/2026 Optionsausübung 14.50 27,999 405,986 Form 4
SYRE Burrows Scott L Chief Financial Officer 09/01/2026 Verkauf 89.04 200 17,808 Form 4
SYRE Burrows Scott L Chief Financial Officer 09/01/2026 Verkauf 88.03 2,016 177,468 Form 4
SYRE Burrows Scott L Chief Financial Officer 09/01/2026 Verkauf 87.11 4,384 381,890 Form 4
SYRE Burrows Scott L Chief Financial Officer 09/01/2026 Verkauf 86.25 900 77,625 Form 4
SYRE Burrows Scott L Chief Financial Officer 09/01/2026 Optionsausübung 14.50 7,500 108,750 Form 4
SYRE Turtle Cameron Chief Executive Officer 09/01/2026 Verkauf 89.07 400 35,628 Form 4
SYRE Turtle Cameron Chief Executive Officer 09/01/2026 Verkauf 88.06 3,700 325,822 Form 4
SYRE Turtle Cameron Chief Executive Officer 09/01/2026 Verkauf 87.15 8,400 732,060 Form 4
SYRE Turtle Cameron Chief Executive Officer 09/01/2026 Verkauf 86.36 2,500 215,900 Form 4
SFM Sinclair Jack Chief Executive Officer 09/01/2026 Verkauf 82.66 10,788 891,700 Form 4
SFM Sinclair Jack Chief Executive Officer 09/01/2026 Optionsausübung 16.47 10,788 177,678 Form 4
SPT Barretto Ryan Paul CEO 09/01/2026 Steuer-Abgabe 11.47 13,323 152,815 Form 4
SPOT Soderstrom Gustav Co-Chief Executive Officer 09/01/2026 Steuer-Abgabe 543.62 117 63,604 Form 4
SPOT Jenkins Dustee Chief Public Affairs Officer 09/01/2026 Steuer-Abgabe 543.62 428 232,669 Form 4
SPOT Luiga Christian Chief Financial Officer 09/01/2026 Steuer-Abgabe 543.62 105 57,080 Form 4
SPOT Lundstrom Anna Chief Human Resources Officer 09/01/2026 Steuer-Abgabe 543.62 249 135,361 Form 4
SPOT Norstrom Alex Co-Chief Executive Officer 09/01/2026 Steuer-Abgabe 543.62 809 439,789 Form 4
SONO Boone Karen Director 09/01/2026 Verkauf 15.39 10,000 153,900 Form 4
SOLV Hanson Bryan C Chief Executive Officer 09/01/2026 Steuer-Abgabe 90.95 26,468 2,407,265 Form 4
SOLV Hanson Bryan C Chief Executive Officer 09/01/2026 Optionsausübung — 67,261 — Form 4
STI Davis John Linzy Director 09/01/2026 Zuteilung — 12,853 — Form 4
STI Tjon Karin-Joyce Director 09/01/2026 J — 200 — Form 4
STI Tjon Karin-Joyce Director 09/01/2026 Zuteilung — 12,853 — Form 4
STI Schwartz Mark N Director 09/01/2026 Zuteilung — 4,296 — Form 4
STI Robinson Dante W Director 09/01/2026 Zuteilung — 4,296 — Form 4
STI Ellen Kimi L Director 09/01/2026 Zuteilung — 4,296 — Form 4
SLGL Opaleye Management Inc. 10% Owner 09/01/2026 Kauf 69.52 783 54,434 Form 4
SNOW Kleinerman Christian EVP, Product Management 09/01/2026 Verkauf 325.57 15,000 4,883,550 Form 4
SDHC Bennett Gregory S See Remarks 09/01/2026 Kauf 12.20 1,000 12,197 Form 4
SKIL Swiniarski Keith C. Chief Accounting Officer 09/01/2026 Steuer-Abgabe 6.53 121 790 Form 4
SKIL Swiniarski Keith C. Chief Accounting Officer 09/01/2026 Optionsausübung — 500 — Form 4
SEPN Long Daniel D. SVP, Drug Discovery 09/01/2026 Verkauf 37.83 3,333 126,078 Form 4
SEPN Long Daniel D. SVP, Drug Discovery 09/01/2026 Optionsausübung 2.76 3,333 9,199 Form 4
STX Mosley William D CEO 09/01/2026 Verkauf 832.05 80 66,564 Form 4
STX Mosley William D CEO 09/01/2026 Verkauf 827.90 120 99,348 Form 4
STX Mosley William D CEO 09/01/2026 Verkauf 826.86 340 281,132 Form 4
STX Mosley William D CEO 09/01/2026 Verkauf 826.00 580 479,079 Form 4
STX Mosley William D CEO 09/01/2026 Verkauf 824.05 1,240 1,021,820 Form 4
STX Mosley William D CEO 09/01/2026 Verkauf 824.93 600 494,961 Form 4

A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).

Was this page helpful to you?